Views: 257 Author: Rchemsell Publish Time: 2026-11-01 Origin: Site
Content Menu
● What Buyers Are Actually Purchasing: Epithalon vs Epithalamin
● Why Source Epithalon From China?
>> A Connected Peptide Manufacturing Ecosystem
>> What Recent Industry Data Can—and Cannot—Tell Buyers
● Top 10 Epithalon Manufacturers in China to Evaluate
>> 1. Rchemsell — Flexible Custom Peptide Project Support
>> 2. GenScript — A Large Research-Service Platform With China Manufacturing
>> 3. GL Biochem — Peptide Synthesis and Upstream Reagent Expertise
>> 4. ChinaPeptides QYAOBIO — Research-Oriented Custom Synthesis
>> 5. Hangzhou Go Top Peptide Biotech — Research-to-Scale Manufacturing
>> 6. Beijing SciLight Biotechnology — Research Peptides and Modifications
>> 7. DGpeptides — Custom Peptides Within a Broader Research Offering
>> 8. Synpeptide — Custom Research Peptides With Identity Checks Required
>> 9. KS V Peptide — A Research and Discovery-Oriented Candidate
>> 10. Hybio Pharmaceutical — A Pharmaceutical Peptide Capability Benchmark
● Capacity, MOQ, and Certification Comparison
● Buyer's Guide: Qualifying an Epithalon Supplier
>> Verify the Factory and Quality System
>> Qualify a Representative Sample
>> An Insider Purchasing Trap: Correct Mass, Wrong Reporting Basis
>> Control Packaging and Shipping
● FAQ
>> 1. How do I verify whether an ISO certificate is still valid?
>> 2. Does 99% purity establish pharmaceutical-grade Epithalon?
>> 3. Can I use a supplier's stated total peptide capacity to estimate Epithalon availability?
>> 4. What should happen if the sample passes but the commercial batch fails?
>> 5. Can research Epithalon automatically be sold as a cosmetic ingredient?
Choosing an Epithalon manufacturer in China requires more than comparing purity percentages and prices. Professional buyers should examine manufacturing identity, peptide synthesis experience, quality-control methods, production scheduling, and the supplier's ability to reproduce an agreed specification.
My recommendation is to prioritize traceability. A competitive quotation has limited value if the supplier cannot connect the delivered material to its manufacturing site, analytical records, and batch-release decision.
China offers several sourcing models: established research-service platforms, specialist peptide manufacturers, pharmaceutical development companies, and flexible custom synthesis partners. The right choice depends on your application, order size, documentation requirements, and expected purchasing frequency.
This guide presents ten companies worth investigating for Epithalon sourcing or custom synthesis inquiries. It is not a verified market-share ranking. Public evidence does not establish that every company maintains current Epithalon inventory, and general peptide capability should not be mistaken for confirmed product availability.
Epithalon, also spelled Epitalon, is a synthetic tetrapeptide with the sequence Ala–Glu–Asp–Gly, commonly abbreviated AEDG.
It should not be confused with epithalamin, a chemically distinct pineal-derived polypeptide preparation. Mixing these names in an inquiry can produce quotations for materials that are not equivalent.
For procurement purposes, specify:
- The AEDG sequence and stereochemistry.
- Terminal groups.
- Counterion or salt requirements.
- Purity and peptide-content requirements.
- Intended research application.
- Required analytical documentation.
This article addresses research sourcing. It does not establish Epithalon's suitability for human treatment or commercial cosmetic use. A supplier's cosmetic peptide experience does not automatically qualify this particular ingredient for a finished cosmetic product.
The Yangtze River Delta provides a useful concentration of peptide capabilities. Shanghai hosts established synthesis businesses, while Jiangsu and Zhejiang contain research, production, and scale-up operations.
Examples include GL Biochem in Shanghai, GenScript's production investment in Zhenjiang, and Go Top's operations in Hangzhou and Shaoxing.
Beijing contributes research-oriented peptide synthesis capabilities through companies such as SciLight. These locations illustrate different strengths rather than a single officially defined "Epithalon manufacturing cluster."
GenScript's 2025 annual report, published in 2026, reported Life Science Group revenue of approximately US$522.1 million, up 14.8% from 2024.
That figure demonstrates the scale of an established research-service platform. It does not measure Epithalon sales or China's Epithalon market.
Similarly, China Customs publishes export statistics for broad pharmaceutical categories, but the reviewed tables do not isolate Epithalon. Buyers should be cautious about reports presenting precise Epithalon export volumes without explaining their methodology.
Based on company-provided information, Rchemsell is a Chinese peptide development and manufacturing business serving laboratory research and cosmetic peptide customers.
- Founded: Not supplied; request registration records.
- Main customer focus: International laboratories and smaller businesses seeking customized peptide services.
- Core capabilities: Company-stated synthesis, testing, lyophilization, packaging, and transportation coordination.
- OEM/ODM scope: Custom synthesis and packaging support, subject to project confirmation.
Rchemsell's proposed value is flexibility: coordinating technical requirements and packaging decisions without requiring buyers to fit an unchanged catalog format.
Its positioning may suit smaller customers seeking attentive communication and cost-conscious customization. These advantages should be tested through quotation clarity, response times, sample quality, and repeat-order performance—not accepted as independently proven.
The company reports purity of 98%–99%. Confirm the analytical method and batch-specific specification for Epithalon. The supplied contact page was not retrievable during research, so certifications, capacity, and founding year remain unverified.
GenScript was founded in 2002 and has documented peptide manufacturing operations in China, including Zhenjiang.
- Founded: 2002.
- Main markets: International academic, biotechnology, and pharmaceutical research.
- Core strength: Broad custom peptide services and an established research-service platform.
- Customization scope: Modified peptides, peptide libraries, and project-specific synthesis; private-label arrangements require confirmation.
GenScript is relevant when buyers need structured technical support or a wider research-service relationship.
Its published service information covers milligram-to-kilogram quantities, but that range is not an Epithalon-specific capacity commitment. Request a current quotation for AEDG, including manufacturing location, analytical deliverables, and available production slots.
GL Biochem was founded in 1998 and is based in Shanghai. Its published portfolio includes custom, catalog, cosmetic, and GMP peptide categories.
- Founded: 1998.
- Main markets: Research and industrial biochemical customers internationally.
- Core strength: Peptides alongside amino acid derivatives, resins, and synthesis reagents.
- Customization scope: Custom peptide synthesis and purification; Epithalon-specific OEM terms require inquiry.
The breadth of its upstream chemistry portfolio makes GL Biochem a relevant technical comparison point.
However, the existence of a GMP peptide category does not establish that a particular Epithalon order would be produced under that scope. Specify the required grade and request supporting evidence.
ChinaPeptides, also identified as QYAOBIO, was established in October 2008. Its official profile describes peptide synthesis, protein expression, and antibody preparation.
- Founded: 2008.
- Main markets: Life science research customers.
- Core strength: Custom peptide work within a broader research-service offering.
- Customization scope: Sequence-defined synthesis and modifications; packaging and private-label services require confirmation.
This company is relevant to laboratories that want peptide supply alongside related biological research services.
Use its established corporate contact channels to request an Epithalon quotation. Verify the contracting entity and payment details rather than assuming similarly named storefronts represent the same business.
Go Top states that it was founded in 2014 and operates peptide research and manufacturing facilities in Zhejiang.
- Founded: 2014.
- Main markets: Research, biotechnology, and pharmaceutical development customers.
- Core strength: A company-described research-to-commercial manufacturing platform.
- Customization scope: Peptide development, pilot production, and manufacturing; Epithalon availability requires confirmation.
Its website states that its quality system is certified to ISO 9001:2015.
Go Top also publishes substantial capacity claims for other peptides. Those figures should not be reassigned to Epithalon. Ask for the capacity actually available for your material and delivery window.
SciLight's company information identifies its establishment in Beijing in 2002.
- Founded: 2002.
- Main markets: Academic, biotechnology, and pharmaceutical research.
- Core strength: Custom synthesis, modifications, purification, and characterization.
- Customization scope: Research-specific sequences and formats; commercial OEM arrangements require discussion.
SciLight is relevant for buyers whose priority is a defined research specification rather than a retail vial format.
Request an explicit quote for unmodified AEDG or the exact variant required. A supplier's ability to synthesize longer or more complex peptides does not remove the need to qualify a short peptide's analytical specification.
DGpeptides' published website lists peptide synthesis, modifications, peptide raw materials, small-molecule synthesis, protein expression, and antibody services.
- Founded: Not verified from the reviewed primary information.
- Main customer focus: Research and development buyers.
- Core strength: Multiple research-service categories.
- Customization scope: Peptide synthesis and modifications; OEM packaging terms require confirmation.
DGpeptides is worth investigating when a project combines peptide work with related synthesis services.
Before qualification, confirm the registered legal entity, operating sites, and activities performed directly. Current Epithalon availability and manufacturing capacity were not established by the reviewed evidence.
Synpeptide's published materials describe custom synthesis, peptide libraries, and isotope-labeled peptides.
- Founded: Its published history states 1998; third-party listings conflict.
- Main markets: International research, biotechnology, and pharmaceutical customers.
- Core strength: Research peptide customization.
- Customization scope: Libraries, labels, and modified sequences; Epithalon OEM services require confirmation.
The conflicting business-history information makes corporate verification particularly important.
Match the legal entity, site address, email domain, quotation, and bank beneficiary before ordering. Historical references to ISO 9001:2008 should not be presented as evidence of a currently valid certificate.
KS V Peptide is based in Hefei and describes peptide discovery and development capabilities. Its professional profile lists establishment in 2018.
- Founded: 2018, according to its professional profile.
- Main customer focus: Peptide research and development.
- Core strength: Discovery-oriented peptide expertise.
- Customization scope: Confirm routine synthesis, packaging, and OEM availability directly.
KS V is a capability-screening candidate rather than a confirmed stocked Epithalon source.
It may be more relevant when the inquiry extends beyond commodity supply into research collaboration. Buyers seeking standard Epithalon alone should first confirm commercial fit and minimum project requirements.
Hybio was founded in 1998 and operates in peptide pharmaceutical development and manufacturing.
- Founded: 1998.
- Main markets: Pharmaceutical development and medicine supply chains.
- Core strength: Peptide APIs and development/manufacturing services.
- Customization scope: Pharmaceutical development services; research Epithalon supply requires explicit confirmation.
Hybio is included as an industrial capability benchmark, not as a verified Epithalon catalog manufacturer.
Its pharmaceutical orientation may not fit small research orders. Confirm willingness to quote, intended-use acceptance, project minimums, and product-specific requirements before investing in a lengthy qualification process.
| Company | Relevant scale evidence | Epithalon MOQ | Certification position |
|---|---|---|---|
| Rchemsell | Company-stated custom synthesis | Request quotation | Not independently verified |
| GenScript | Published mg-to-kg peptide services | Request quotation | Verify relevant site and scope |
| GL Biochem | Research and industrial peptide categories | Request quotation | Verify current, order-relevant evidence |
| ChinaPeptides | Custom peptide research platform | Request quotation | Request current certificates |
| Go Top | Research-to-scale platform claims | Request quotation | Company states ISO 9001:2015 |
| SciLight | Custom research peptide services | Request quotation | Request current certificates |
| DGpeptides | Custom synthesis services | Request quotation | Not established here |
| Synpeptide | Custom peptides and libraries | Request quotation | Historical statements require updating |
| KS V Peptide | Discovery/development platform | Confirm project acceptance | Not established here |
| Hybio | Pharmaceutical peptide manufacturing | Confirm project acceptance | Product and site scope require verification |
CE marking and RoHS documentation are not appropriate substitutes for peptide identity, analytical quality, or manufacturing-system evidence. Environmental certification, where relevant, is also separate from product quality.
Request the legal entity, manufacturing address, testing location, and explanation of outsourced activities.
For an ISO claim, check the certificate number, covered site, scope, expiry date, and issuing body. A certificate covering distribution does not automatically cover synthesis.
Agree on acceptance criteria before testing.
Request batch-linked identity and purity data. Depending on the application, assess peptide content, water, counterions, relevant impurities, and experimental performance.
Determine whether the sample comes from the proposed commercial lot or a separate demonstration batch.
An expected molecular mass does not establish every attribute of the material.
Likewise, HPLC purity is not the same as peptide content. Moisture and counterions can affect the amount of peptide represented by a weighed powder sample.
Ask suppliers to define labeled quantity, analytical purity, and content separately. Compare quotations against equivalent specifications—not vial weight alone.
Request material-specific storage and shipment instructions.
Clarify packaging, customs documentation, clearance responsibilities, and procedures for damaged or delayed shipments. Research-use descriptions must accurately reflect the transaction, not serve as a workaround for destination-country requirements.
China offers multiple peptide sourcing models, but company size and advertised purity do not establish Epithalon suitability.
Start with two or three technically relevant candidates. Verify their identity, request equivalent quotations, qualify representative material, and evaluate repeat-batch controls.
Confirm its status with the issuing certification body using independently obtained contact details. Check the legal entity, address, scope, dates, and whether the relevant manufacturing activity is covered.
No. A purity percentage does not establish pharmaceutical authorization, sterility, comprehensive impurity control, or suitability for human use.
Not reliably. Equipment utilization, production scheduling, purification requirements, and other orders affect available capacity. Request a product-specific commitment.
Quarantine the batch and follow a predefined investigation procedure. The agreement should cover retained samples, method comparison, independent testing, replacement, and rejection criteria.
No. Research use and cosmetic commercialization require different assessments. Confirm ingredient suitability, safety evidence, formulation requirements, and destination-market rules before commercial use.
1. Cayman Chemical. "Epitalon," Product Information, Item 39177. Reference for compound identity and research context. [cdn.caymanchem]
2. "Epitalon and Epithalamin: A Narrative Review of Mechanistic…" Published in 2026; distinguishes the defined tetrapeptide from the pineal-derived preparation and discusses evidence limitations. [pmc.ncbi.nlm.nih]
3. GenScript Biotech Corporation. "2025 Annual Report," published through HKEX in April 2026. Source for Life Science Group revenue; not an Epithalon market report. [www1.hkexnews]
4. General Administration of Customs of China. "Major Export Commodities in Quantity and Value, January–April 2025." Broad pharmaceutical export context; no isolated Epithalon series. [english.customs.gov]
5. GenScript. Official peptide service information, and reporting on its Zhenjiang expansion. [genscript]
6. GL Biochem. Official product categories and company profile information. [glbiochem]
7. ChinaPeptides. Official company profile, including its October 2008 establishment. [chinapeptides]
8. Hangzhou Go Top Peptide Biotech. "About Us." Company-provided establishment, facility, capacity, and certification claims. [gtpeptide]
9. Beijing SciLight Biotechnology. Company and technical service information. [scilight-peptide]
10. DGpeptides. Official service description. [dgpeptides]
11. Synpeptide. Published history and service descriptions; conflicting third-party establishment information is disclosed rather than resolved by assumption. [synpeptide]
12. KS V Peptide. Company website and professional profile. [ks-vpeptide]
13. Hybio Pharmaceutical. Company profile and official report archive. [finance.yahoo]
